{"id":"W7019667144","doi":"","title":"HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infection","year":2016,"lang":"en","type":"other","venue":"Dove Medical Press (Taylor and Francis Group)","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Genentech; H. Lundbeck A/S; Astellas Pharma; ViiV Healthcare; Gilead Sciences; Sanofi; Pfizer","keywords":"Ribavirin; Chronic hepatitis; Hepatitis C virus; Pegylated interferon; University hospital; Hepatitis C","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001558974,0.0007141587,0.001132695,0.0002547163,0.0003280778,0.0008825231,0.0003211409,0.0008090275,0.002688398],"category_scores_gemma":[0.002082275,0.000404896,0.000992634,0.000284436,0.0002847652,0.0006723384,0.000338584,0.001114053,0.0003326097],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005769449,"about_ca_system_score_gemma":0.0007373635,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000829537,"about_ca_topic_score_gemma":0.003216142,"domain_scores_codex":[0.9987867,0.0006436304,0.00006773226,0.0001838809,0.0001407229,0.0001772445],"domain_scores_gemma":[0.9994673,0.0001954303,0.0001068984,0.00002557241,0.00002639902,0.0001783456],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4540579,0.008123522,0.2627418,0.0006141262,0.002525745,0.001114859,0.0004069589,0.001977365,0.01070611,0.0005536221,0.006183283,0.2509947],"study_design_scores_gemma":[0.08987976,0.1131996,0.7566986,0.0006985924,0.002921215,0.002454389,0.0006858321,0.01345353,0.005105606,0.0009434595,0.01377606,0.0001832784],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936972,0.003146418,0.0001783805,0.0005654111,0.0001801753,0.0001427219,0.0002619592,0.00002007759,0.001807671],"genre_scores_gemma":[0.996751,0.0006442479,0.0004758636,0.0004899724,0.0001628603,0.0001440942,0.0004894194,0.00001089267,0.0008316422],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002688398,"threshold_uncertainty_score":0.008993626,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02078589790490834,"score_gpt":0.291575797532289,"score_spread":0.2707898996273806,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}